Euro Biotechnology

Immigrants are more likely to start their own business than people born in the UK, according to a Global Entrepreneurship Monitor report

Here is a recap of what happened in the search forums today…

So we just had Google AdWords announce banning payday loan ads and now Bing announced they are banning third party online technical support services to consumers.

So those who have technical support companies directed at consumers can no longer use Bing Ads to promote their business…

Newly spun out company OxStem has raised £16.9m (€21.5m) to develop regenerative meds for the treatment of age-related disease. It is the largest financing for an Oxford spin-out – or any UK academic spin-out – to date.

Student Chris Parnell has been nominated in the Aspiring Talent category at the BYPY Awards.

Here is a recap of what happened in the search forums today, through the eyes of the Search Engine Roundtable and other search forums on the web…

Swiss Genentech partner AC Immune has raised CHF42.7m (€38.6m) in order to advance its therapeutic and diagnostic product pipeline in Alzheimer’s disease. The news follows a recently announced R&D collaboration with Biogen.

The Lord does not look at the things people look at. People look at the outward appearance, but the Lord looks at the heart.

– 1 SAMUEL 16:7

How well is the biotechnology branch doing? The annual figures for the sector obtained by biotechnologie.de – based on internationally comparable standards from the Organisation for Economic Co-operation and Development (OECD) – show that German companies are doing surprisingly well.

An expert panel’s final report on the fatal drug trial earlier this year in France states that the death of one of the participants was most likely caused by the drug’s toxicity and not by any violation of the rules.